JIP
REGN icon

Jaffetilchin Investment Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Jaffetilchin Investment Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-220
Closed -$231K – 1086
2024
Q3 		$231K Sell
220
-25
-10% -$27.8K 0.02% 332
2024
Q2 		$258K Sell
245
-2
-0.8% -$1.94K 0.02% 298
2024
Q1 		$238K Sell
247
-19
-7% -$18.1K 0.02% 321
2023
Q4 		$234K Hold
266
– – 0.02% 308
2023
Q3 		$219K Sell
266
-25
-9% -$19.6K 0.02% 312
2023
Q2 		$209K Buy
+291
New +$224K 0.02% 337
2021
Q4 		– Sell
-458
Closed -$277K – 375
2021
Q3 		$277K Sell
458
-903
-66% -$561K 0.03% 284
2021
Q2 		$696K Buy
1,361
+688
+102% +$349K 0.05% 217
2021
Q1 		$318K Sell
673
-183
-21% -$89.1K 0.04% 259
2020
Q4 		$414K Buy
+856
New +$462K 0.06% 184
2020
Q2 		– Sell
-604
Closed -$295K – 233
2020
Q1 		$295K Buy
+604
New +$249K 0.1% 120
2019
Q2 		– Sell
-879
Closed -$361K – 322
2019
Q1 		$361K Buy
879
+293
+50% +$121K 0.08% 192
2018
Q4 		$219K Sell
586
-2,595
-82% -$950K 0.05% 232
2018
Q3 		$1.28M Sell
3,181
-3
-0.1% -$1.14K 0.27% 65
2018
Q2 		$1.1M Buy
+3,184
New +$996K 0.24% 75
2016
Q1 		– Sell
-981
Closed -$533K – 235
2015
Q4 		$533K Buy
+981
New +$532K 0.17% 95
2013
Q3 		– Sell
-1,618
Closed -$364K – 191
2013
Q2 		$364K Buy
+1,618
New +$377K 0.25% 108

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jaffetilchin Investment Partners's REGN Position: Q4 2024 in Review

Jaffetilchin Investment Partners sold out of Regeneron Pharmaceuticals (REGN) in Q4 2024, closing a stake of 220 shares — an estimated $231K sold.

Jaffetilchin Investment Partners first reported a position in REGN in Q2 2013 and held it in 17 quarters. The position peaked at $1.28M in Q3 2018. 1,318 funds tracked by Wall St. Rank hold REGN as of Q4 2024.

  • Jaffetilchin Investment Partners reported no remaining Regeneron Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 220 Regeneron Pharmaceuticals shares in Q4 2024, an estimated $231K.
  • Jaffetilchin Investment Partners first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Jaffetilchin Investment Partners's Regeneron Pharmaceuticals position peaked at $1.28M in Q3 2018.
  • 1,318 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2024.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.